Evidence Hub

Polymer stabilized amorphous dispersions of clonazepam: characterization and in vitro dissolution analysis

Khurshid Jahan, TONMOY BHOWMICK, JANNATUL FERDOUSI, SHIHAB HOSSAIN, NAHID HASAN SHUVO

International Journal of Applied Pharmaceutics, 2026

Abstract

Objective: The objective of this study is to enhance the aqueous solubility and dissolution rate of poorly water soluble clonazepam (CLZ) by formulating polymer stabilized amorphous solid dispersions (ASDs) using melting and co-precipitation methods. The study systematically evaluates the effect of various hydrophilic polymers at different drug to polymer ratios on the physicochemical properties, dissolution behavior, and stability of the resulting solid dispersions (SDS). This research aims to optimize polymer selection and preparation techniques to improve the bioavailability and therapeutic efficacy of clonazepam, addressing current gaps in comparative studies of polymer based solubility enhancement strategies for this drug. Methods: SDS of CLZ were prepared using melting and co-precipitation methods with four hydrophilic polymers (HPMC K4MCR, PEG 6000, Methocel K15, and Kollidon Cl) at drug to polymer ratios of 1:1, 1:3, and 1:5. The formulations were characterized through in vitro dissolution studies, drug content analysis, and structural evaluations using Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimetry (DSC), and Scanning Electron Microscopy (SEM). Results: The pure CLZ showed limited solubility (51±0.577%) at 60 min, whereas polymer ASDs significantly enhanced drug release. The PEG 6000 based formulation (ASD9, 1:5 ratio) exhibited the highest improvement (80.95±0.460%), followed by HPMC K4MCR (ASD3, 75.95±0.033%). Enhanced…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free